A Chinese cancer precision diagnostics firm 3D Medicines recently completed a 280 million yuan (US$40 million) financing for its diagnostic business segment.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
